Biochemical recurrence prediction after radiotherapy for prostate cancer with T2w magnetic resonance imaging radiomic features

Biochemical recurrence prediction after radiotherapy for prostate cancer with T2w magnetic resonance imaging radiomic features

Background and purpose: High-risk prostate cancer patients are frequently treated with external-beam radiotherapy (EBRT). Of all patients receiving EBRT, 15–35% will experience biochemical recurrence (BCR) within five years. Magnetic resonance imaging (MRI) is commonly acquired as part of the diagno...

Full description

Bibliographic Details
Main Authors: Catarina Dinis Fernandes, Cuong V. Dinh, Iris Walraven, Stijn W. Heijmink, Milena Smolic, Joost J.M. van Griethuysen, Rita Simões, Are Losnegård, Henk G. van der Poel, Floris J. Pos, Uulke A. van der Heide
Format: Article
Language:English
Published: Elsevier 2018-07-01
Series:Physics and Imaging in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2405631617300854

Internet

http://www.sciencedirect.com/science/article/pii/S2405631617300854

Similar Items